| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bead2273f5271db16725af34a845fee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_522686109a723d0962a8c90cfd6d4ace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09b9b0d00436d3b83db8660b299524d1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| filingDate |
2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a381ca2c1489fce70cc0c8cb853fe64a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91fa887daefddc6b643d979cc42a9d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a8524ebcd451004f85cb4780d3b14fe |
| publicationDate |
2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006022407-A1 |
| titleOfInvention |
Adjuvant therapy with the use of anti-glypican 3 antibody |
| abstract |
It is intended to provide an anticancer agent containing anti-glypican 3 antibody characterized by being administered after a treatment for cancer. The term “after a treatment for cancer” preferably means after a treatment for liver cancer, and “after a treatment for liver cancer” still preferably means after the removal of liver cancer cells. This anticancer agent is preferably employed in the case where glypican 3 is expressed in the removed liver cancer cells. It is also preferable that the anti-glypican 3 antibody is a monoclonal antibody. This anticancer agent is efficacious in preventing cancer or preventing cancer recurrence. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919086-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9217033-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8680247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7867734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013500261-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001643-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10118959-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047291-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013540424-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047291-A3 |
| priorityDate |
2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |